Close

Prof David Moore

Prof. of Infectious Disease & Tropic Med

United Kingdom

My primary research interest is in control of tuberculosis and drug-resistant tuberculosis through innovative strategies for diagnosis of adult and paediatric TB, management of latent TB infection and drug-susceptible and drug-resistant active TB disease, and institutional and domestic TB infection control.

MODS delivers rapid, low-cost diagnosis of MDR-TB but important by-products of this enhanced diagnostic testing include identification of a large number of MDR-exposed household contacts and individuals with isoniazid resistant (non-MDR) TB.

We are interested in an experimental medicine approach exploring transcriptomic responses to preventive therapy for contacts exposed to drug-susceptible TB with an eye to future evaluations of preventive therapy for MDR-exposed contacts.

We believe we have demonstrated that subjects with evidence of TB sensitisation (positive IGRA or TST) can be separated into those who still have viable TB infection capable of future reactivation and those who do not, through observing their transcriptomic response to TB preventive therapy - explained in this short animation, [1] https://www.youtube.com/watch?v=W5MG9IhVv80 and the linked publication.

We have also developed a DHIS-2 MDR-TB contact registry module to enhance capacity of programmes to identify and track MDR contacts and to create a ready-to-go line list of individuals eligible for MDR preventive therapy in the event that current ongonig trials identify an efficacious regimen.

In London, aligned with my clinical tropical medicine practice at the Hospital for Tropical Diseases (UCLH), we are leading operational research into implementation of screening for Chagas disease in Latin American migrants now living in the UK. We have established a UK Chagas Hub for clinicians, scientists and members of the Latin American community to come together to explore ways to optimise clinical pathways, raise awareness and undertake research, with a YouTube channel, Facebook and Twitter presence, @ukchagashub

As our clinical cohort of patients under follow-up for Chagas disease continues to grow we are embarking upon longitudinal studies in this diverse population.

Affiliations

Department of Clinical Research
Faculty of Infectious and Tropical Diseases

Centres

Centre for Evaluation
TB Centre
Antimicrobial Resistance Centre

Teaching

Course Director, Diploma in Tropical Medicine and Hygiene (2010-)

Teaching Faculty, MSc in Tropical Medicine and International Health (TMIH) and MSc in Control of Infectious Diseases (CID)

Research

Research Area
Clinical care
Diagnostics
Disease control
Global Health
Mobile technologies
Pharmacokinetics
Bacteriology
Epidemiology
Genomics
Medicine
Molecular epidemiology
Operational research
Implementation science
AMR (Antimicrobial resistance)
Disease and Health Conditions
Chagas Disease
Neglected Tropical Diseases (NTDs)
Tropical diseases
Tuberculosis
Infectious diseases
Country
Bhutan
Peru
Somalia
South Africa
Uganda
Region
Latin America & Caribbean (developing only)
Sub-Saharan Africa (all income levels)

Selected Publications

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
NYANG'WA, B-T; Berry, C; Kazounis, E; Motta, I; Parpieva, N; Tigay, Z; Solodovnikova, V; Liverko, I; Moodliar, R; DODD, M; Ngubane, N; Rassool, M; McHugh, TD; Spigelman, M; MOORE, DA J; Ritmeijer, K; Du Cros, P; FIELDING, K; TB-PRACTECAL Study Collaborators,;
2022
New England Journal of Medicine
Understanding the biology, morbidity and social contexts of adolescent tuberculosis: a prospective observational cohort study protocol (Teen TB)
Swanepoel, J; Zimri, K; Van der Zalm, MM; Hoddinott, G; Palmer, M; Doruyter, A; De Beer, G; Kleynhans, L; Johnson, SM; Jongen, V; Wademan, D; Mcimeli, K; Jacobs, S; Swanepoel, R; Van Zyl, G; Allwood, BW; Malherbe, S; Heuvelings, C; Griffith-Richards, S; Whittaker, E; MOORE, DA J; Schaaf, HS; Hesseling, AC; Seddon, JA;
2022
BMJ Open
Evaluation of three alternatives cost-effective culture media for Mycobacterium tuberculosis detection and drug susceptibility determination using the microscopic observation drug susceptibility (MODS) assay.
Rodriguez, J; Alcántara, R; Rodríguez, J; Vargas, J; Roncal, E; Antiparra, R; Gilman, RH; Grandjean, L; MOORE, D; Zimic, M; Sheen, P;
2022
Tuberculosis (Edinburgh, Scotland)
Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru.
Puyén, ZM; Santos-Lázaro, D; Vigo, AN; Coronel, J; Alarcón, MJ; Cotrina, VV; MOORE, DA J;
2022
BMC Infectious Diseases
Latent Tuberculosis Infection Care.
GASKELL, KM; Pillay, TD; Brown, J; Belton, M; Mepham, SO; MOORE, DA J; Lipman, M;
2022
Clinical Infectious Diseases
Diagnosis and Clinical Management of Chagas Disease: An Increasing Challenge in Non-Endemic Areas.
Suárez, C; NOLDER, D; García-Mingo, A; MOORE, DA J; Chiodini, PL;
2022
Research and Reports in Tropical Medicine
See more information